VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33410241/
1 Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan. 2 Department of Allergy and Respiratory Medicine, Okayama University Hospital,...
Reasonable Timing of Radiotherapy for Stage IV Non-Small-Cell Lung Cancer During Targeted Therapy Based on Tumour Volume Change - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34631535/
doi: 10.3389/fonc.2021.705303. 1 Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China. 2 Department of Oncology, Guizhou Cancer Hospital, Guiyang, China. 3 Department of Oncology, Guiyang Guihang Hospital,...
-
NSCLC Connect4yrKey Points • Source: Frontiers in Oncology • Conclusion/Relevance: “To obtain a high radiation dose and control radiation toxicity, the 40th day after targeted therapy may be a reasonable time to start Show More
A contemporary review of rearranged during transfection-selective inhibitors - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34590525/
doi: 10.1177/10781552211040542. Online ahead of print. 1 College of Pharmacy and Health Sciences, Department of Clinical Health Professions, 4131St John's University, NY, USA. 2 Division of Medical Oncology and Hematology,...
Prognostic impact of immune inflammation biomarkers in predicting survival and radiosensitivity in patients with non-small-cell lung cancer treated with chemoradiotherapy - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34632714/
doi: 10.1111/1754-9485.13341. Online ahead of print. 1 Department of Radiation Oncology, Samsun Training and Research Hospital, Health Sciences University, Samsun, Turkey. 2 Department of Medical Oncology, İstinye University, İstanbul, Turkey....
Efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancer: A multicenter retrospective cohort study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34602370/
The efficacy of RAM plus DOC administration in older, pretreated patients with advanced NSCLC was comparable to those of younger patients, whereas RAM plus DOC should be cautiously administered to...